Company Valuation: Atossa Therapeutics, Inc.

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 202.6 66.92 110.3 118.8 76.21 18.96 - -
Change - -66.97% 64.77% 7.71% -35.83% -75.12% - -
Enterprise Value (EV) 202.6 66.92 110.3 118.8 76.21 18.96 18.96 18.96
Change - -66.97% 64.77% 7.71% -35.83% -75.12% 0% 0%
P/E -8.89x -2.52x -3.67x -4.72x -2.19x -0.55x -0.69x 0.76x
PBR 1.47x 0.57x 1.22x 1.69x 1.92x - - -
PEG - -0.2x -0.3x 0.3x -0.1x 0x 0x -0x
Capitalization / Revenue - - - - - - - 0.16x
EV / Revenue - - - - - - - 0.16x
EV / EBITDA - - - - - - - -
EV / EBIT -0x -0x -0x -0x -0x -0.57x -0.5x 0.38x
EV / FCF - - - - - - - -
FCF Yield - - - - - - - -
Dividend per Share 2 - - - - - - - -
Rate of return - - - - - - - -
EPS 2 -2.7 -3.15 -3.6 -3 -4.04 -3.46 -2.737 2.49
Distribution rate - - - - - - - -
Net sales 1 - - - - - - - 118.7
EBITDA - - - - - - - -
EBIT 1 -20.52 -27.69 -31.38 -27.62 -37.14 -33.21 -37.99 49.52
Net income 1 -20.61 -26.96 -30.09 -25.5 -34.77 -32.47 -37.99 49.52
Net Debt - - - - - - - -
Reference price 2 24.000 7.927 13.200 14.161 8.850 1.900 1.900 1.900
Nbr of stocks (in thousands) 8,442 8,442 8,354 8,387 8,611 9,979 - -
Announcement Date 2/28/22 3/22/23 4/1/24 3/25/25 3/25/26 - - -
1USD in Million2USD
Estimates

P/E, Detailed evolution



P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
-0.55x - - - 18.96M
17.32x6.64x12.72x1.72% 66.37B
31.83x8.5x28.08x0.07% 58.86B
38.41x6.84x20.46x0.85% 55.22B
44.35x6.2x29.52x-.--% 47.21B
33.62x3.22x13.9x-.--% 42.45B
35.98x8.9x23.21x0.36% 36.44B
-19.28x55.7x-21.11x-.--% 35.19B
41.59x8.02x26.91x-.--% 32.66B
-74.36x14.09x-75.73x-.--% 26.73B
Average 14.89x 13.12x 6.44x 0.33% 40B
Weighted average by Cap. 21.61x 11.64x 11.39x 0.44%

Y-o-Y evolution of P/E

Valuation ratios - P/E - Atossa Therapeutics, Inc.

Historical PBR trend

Valuation ratios - PBR - Atossa Therapeutics, Inc.

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - Atossa Therapeutics, Inc.

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - Atossa Therapeutics, Inc.

  1. Stock Market
  2. Stocks
  3. ATOS Stock
  4. Valuation Atossa Therapeutics, Inc.